tiprankstipranks
Glenmark Life Sciences Limited (IN:ALIVUS)
:ALIVUS
India Market
ALIVUS
Glenmark Life Sciences Limited
RESEARCH TOOLSreports
Want to see IN:ALIVUS full AI Analyst Report?

Glenmark Life Sciences Limited (ALIVUS) Ratios

4 Followers

Glenmark Life Sciences Limited Ratios

IN:ALIVUS's free cash flow for Q2 2025 was ₹0.43. For the 2025 fiscal year, IN:ALIVUS's free cash flow was decreased by ₹ and operating cash flow was ₹0.30. See a summary of the company’s cash flow.
Ratios
TTM
Mar 24Mar 22Mar 21Mar 19
Liquidity Ratios
Current Ratio
 5.06 4.97 4.60 1.15 0.67
Quick Ratio
 3.58 3.53 3.25 0.73 0.38
Cash Ratio
 0.04 0.15 1.33 0.09 <0.01
Solvency Ratio
 0.99 0.92 1.10 0.31 0.22
Operating Cash Flow Ratio
 0.88 0.88 1.56 0.32 <0.01
Short-Term Operating Cash Flow Coverage
 57.35 72.84 -530.71 0.42 492.95
Net Current Asset Value
₹ 18.53B₹ 17.41B₹ 13.48B₹ 1.55B₹ -4.57B
Leverage Ratios
Debt-to-Assets Ratio
 0.03 0.02 <0.01 0.47 <0.01
Debt-to-Equity Ratio
 0.04 0.02 <0.01 1.24 <0.01
Debt-to-Capital Ratio
 0.04 0.02 <0.01 0.55 <0.01
Long-Term Debt-to-Capital Ratio
 0.02 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.21 1.21 1.20 2.65 16.74
Debt Service Coverage Ratio
 49.10 68.05 18.06 0.46 218.85
Interest Coverage Ratio
 133.74 258.41 20.70 6.42 389.76
Debt to Market Cap
 <0.01 <0.01 >-0.01 0.12 <0.01
Interest Debt Per Share
 9.67 4.82 2.62 94.65 0.05
Net Debt to EBITDA
 0.12 -0.02 -0.81 1.38 >-0.01
Profitability Margins
Gross Profit Margin
48.59%32.20%50.88%51.97%55.41%
EBIT Margin
29.70%27.68%27.92%29.63%28.79%
EBITDA Margin
33.06%30.24%29.71%31.40%17.66%
Operating Profit Margin
28.88%26.30%27.27%29.80%16.78%
Pretax Profit Margin
29.48%27.58%26.61%24.98%28.74%
Net Profit Margin
22.05%20.47%19.72%18.65%20.83%
Continuous Operations Profit Margin
22.05%20.47%19.72%18.65%20.83%
Net Income Per EBT
74.81%74.24%74.12%74.65%72.47%
EBT Per EBIT
102.10%104.86%97.58%83.84%171.26%
Return on Assets (ROA)
14.94%14.24%16.95%17.60%19.84%
Return on Equity (ROE)
18.64%17.24%20.38%46.71%332.11%
Return on Capital Employed (ROCE)
22.61%21.21%27.74%72.42%248.26%
Return on Invested Capital (ROIC)
16.87%15.68%20.56%24.65%179.88%
Return on Tangible Assets
15.03%14.32%17.02%17.67%19.92%
Earnings Yield
4.32%3.83%7.77%4.36%3.19%
Efficiency Ratios
Receivables Turnover
 2.46 2.35 3.15 2.76 3.04
Payables Turnover
 3.09 4.12 3.56 4.07 3.34
Inventory Turnover
 1.75 2.39 2.02 1.76 1.56
Fixed Asset Turnover
 2.20 2.27 3.14 3.26 2.65
Asset Turnover
 0.68 0.70 0.86 0.94 0.95
Working Capital Turnover Ratio
 1.28 0.00 2.73 124.63 -6.23
Cash Conversion Cycle
 238.50 219.71 193.92 249.33 244.30
Days of Sales Outstanding
 148.48 155.36 115.78 132.10 119.94
Days of Inventory Outstanding
 208.07 152.97 180.68 206.96 233.55
Days of Payables Outstanding
 118.05 88.63 102.54 89.73 109.19
Operating Cycle
 356.55 308.34 296.46 339.05 353.49
Cash Flow Ratios
Operating Cash Flow Per Share
 35.27 33.58 50.85 36.00 0.84
Free Cash Flow Per Share
 19.50 20.01 39.60 29.69 0.08
CapEx Per Share
 15.78 13.56 11.25 6.31 0.76
Free Cash Flow to Operating Cash Flow
 0.55 0.60 0.78 0.82 0.10
Dividend Paid and CapEx Coverage Ratio
 1.70 2.48 2.29 5.71 1.11
Capital Expenditure Coverage Ratio
 2.24 2.48 4.52 5.71 1.11
Operating Cash Flow Coverage Ratio
 3.82 7.27 207.21 0.42 492.95
Operating Cash Flow to Sales Ratio
 0.18 0.17 0.28 0.21 <0.01
Free Cash Flow Yield
1.90%1.94%8.63%3.97%0.01%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 23.13 26.09 12.88 22.95 31.34
Price-to-Sales (P/S) Ratio
 5.10 5.34 2.54 4.28 6.53
Price-to-Book (P/B) Ratio
 4.17 4.50 2.62 10.72 104.07
Price-to-Free Cash Flow (P/FCF) Ratio
 52.62 51.66 11.59 25.21 8.93K
Price-to-Operating Cash Flow Ratio
 29.06 30.79 9.02 20.79 885.93
Price-to-Earnings Growth (PEG) Ratio
 0.40 0.00 1.39 1.87 >-0.01
Price-to-Fair Value
 4.17 4.50 2.62 10.72 104.07
Enterprise Value Multiple
 15.56 17.64 7.74 15.01 36.95
Enterprise Value
 126.77B 126.53B 48.83B 88.86B 91.69B
EV to EBITDA
 15.56 17.64 7.74 15.01 36.95
EV to Sales
 5.14 5.33 2.30 4.71 6.53
EV to Free Cash Flow
 53.01 51.60 10.49 27.76 8.93K
EV to Operating Cash Flow
 29.30 30.76 8.17 22.90 885.73
Tangible Book Value Per Share
 244.20 228.29 173.91 69.09 6.67
Shareholders’ Equity Per Share
 245.83 229.92 174.80 69.82 7.19
Tax and Other Ratios
Effective Tax Rate
 0.25 0.26 0.26 0.25 0.28
Revenue Per Share
 200.98 193.57 180.66 174.87 114.67
Net Income Per Share
 44.32 39.63 35.63 32.61 23.89
Tax Burden
 0.75 0.74 0.74 0.75 0.72
Interest Burden
 0.99 1.00 0.95 0.84 1.00
Research & Development to Revenue
 0.00 0.00 0.03 <0.01 <0.01
SG&A to Revenue
 0.04 0.02 <0.01 <0.01 <0.01
Stock-Based Compensation to Revenue
 0.00 0.00 <0.01 0.00 0.00
Income Quality
 0.82 0.63 1.06 0.82 0.05
Currency in INR